Ignite Creation Date:
2024-05-06 @ 1:22 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04005144
Status:
TERMINATED
Last Update Posted:
2022-10-17
First Post:
2019-06-28
Brief Title:
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-28
First Submit QC Date:
June 28 2019
Study First Post Date:
2019-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-13
Last Update Post Date:
2022-10-17
Last Update Post Date Type:
ACTUAL